KKR Genetic Disorder L.P., 10% Owner at BridgeBio Pharma, Inc. (BBIO), sold 4,779,380 shares at $33.39 ($159.6M) on 2020-05-28, disclosed to the SEC on 2020-06-01.
Open-market sale of $159.6M BBIO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.39 | 2,389,690 | $79.8M | 50.0% |
| 2 | $33.39 | 2,389,690 | $79.8M | 50.0% |
| Total | $33.39 avg | 4,779,380 | $159.6M | 100% |